Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2017-01-01
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This is a prospective study. Healthy volunteers are randomised in cross-over between spontaneous breathing or noninvasive ventilation pressure support preoxygenation in the presence or absence of a calibrated leak on the inspiratory circuit.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoxygenation Using High Flow Oxygen : Efficacy and Tolerance in Healthy Volunteers
NCT03399695
Ventilation Strategies During Spontaneous Breathing Trial
NCT02939963
Impact of Non-intentional Leaks on Noninvasive Ventilation
NCT00983411
High Flow Oxygen During Spontaneous Breathing Trial in Patients With High Weaning Risk Failure: Impact on the Weaning Course at D7 From the First Spontaneous Breathing Trial.
NCT03689309
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
NCT03026322
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We planned an experimental study with healthy volunteers (residents in anesthesiology).
Healthy volunteers are randomised in cross-over between preoxygenation through spontaeous breathing or noninvasive ventilation pressure support preoxygenation in the presence or absence of a calibrated leak on the inspiratory circuit. The inspiratory fraction of oxygen is 100%. The exhaled gas (oxygen and carbon dioxide) are monitored.The subjects breathed through a mouthpiece (with a nose clip) connected to an anesthetic ventilator.
The primary endpoint is the time to achieve end expiratory fraction of oxygene of 90% or more.
The secondary endpoint is the proportion of subject with end expiratory fraction of oxygen of 90% or more after a 3 min period (recommended in clinical guidelines).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
spontaneous breathing
preoxygenation through spontaneous breathing of 100% oxygen gas flow with or without an inward air leak
preoxygenation without inward leak
breathing a 100% inspired oxygen gas flow during 3 to 10 minutes
preoxygenation with inward leak
breathing a 100% inspired oxygen gas flow during 3 to 10 minutes with an inward air leak made possible through a specific calibrated piece on the inspiratory branch
pressure support ventilation
preoxygenation through non invasive pressure support ventilation of 100% oxygen gas flow (inspiratory trigger sensitivity set at -2 l.min-1, the positive inspiratory support set at +6 cmH2O, the PEEP set at +5 cmH2O and the maximal airway pressure was limited at 15 cmH2O.) with or without an inward air leak
preoxygenation without inward leak
breathing a 100% inspired oxygen gas flow during 3 to 10 minutes
preoxygenation with inward leak
breathing a 100% inspired oxygen gas flow during 3 to 10 minutes with an inward air leak made possible through a specific calibrated piece on the inspiratory branch
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
preoxygenation without inward leak
breathing a 100% inspired oxygen gas flow during 3 to 10 minutes
preoxygenation with inward leak
breathing a 100% inspired oxygen gas flow during 3 to 10 minutes with an inward air leak made possible through a specific calibrated piece on the inspiratory branch
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* active tobaco
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
jean-luc hanouz, m.D,ph.d
Role: PRINCIPAL_INVESTIGATOR
CHU de Caen and universite Caen Normandie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Caen
Caen, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hanouz JL, Le Gall F, Gerard JL, Terzi N, Normand H. Non-invasive positive-pressure ventilation with positive end-expiratory pressure counteracts inward air leaks during preoxygenation: a randomised crossover controlled study in healthy volunteers. Br J Anaesth. 2018 Apr;120(4):868-873. doi: 10.1016/j.bja.2017.12.002. Epub 2018 Jan 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A15-D28-VOL.25
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.